Health Industry

941 - 960 of 30,013 Results

  • FDA OKs Trial For Gene-Edited Pig Kidney Transplants

    Stat reports that Boston-based eGenesis will likely begin the study early next year, aimed at helping patients with end-stage kidney disease. Other pharma and tech news is on Novartis, Summit Therapeutics, "smart cartilage," and more.

  • FTC’s Sole Democrat Caught In Fray As Agency Abandons Noncompete Bans

    President Donald Trump had fired Commissioner Rebecca Slaughter in March, but she won a court reprieve and was reinstated. On Monday, however, the Supreme Court halted that lower court ruling. Meanwhile, the FTC voted 3-1 last week on the noncompete issue; Slaughter cast the dissenting vote. In a statement reported by Modern Healthcare, Slaughter said tossing the regulation was another attempt by Trump to 鈥渢hrow workers under the bus to ingratiate himself with corporations.鈥

  • White House Signals Cuts To Poor Americans’ SSI Disability Benefits

    The proposed reversal would end the Biden-era rule for Supplemental Security Income that allowed those in need to still receive it even if someone in the household was on SNAP. It could affect hundreds of thousands of poor Americans. Meanwhile, California looks to ban private companies from charging fees to help file veterans鈥 disability claims.

  • RFK Jr. Expected To Tie Tylenol Use During Pregnancy With Autism

    A Department of Health and Human Services report, due out this month, will look at other potential causes of autism. It also will explore leucovorin as a means to lessen symptoms, people familiar with the report indicate. Plus, the Autism Science Foundation issues a response.

  • Walgreens Private Equity Deal May Mean Closures, Threaten Patient Access

    As part of the deal, Walgreens will be split into five privately owned companies, but experts warn that private equity takeovers often mean store closures, reduced staffing, and prescription errors. Sycamore Partners has no background in health care or retail pharmacy. Also, Sen. Elizabeth Warren (D-Mass.) warns the buyout may run the company into the ground.

  • Trump Administration To Distribute Gilead’s New HIV Meds To Millions

    As plans for PEPFAR's future move forward, up to 2 million people in lower-income countries will receive Gilead Sciences' HIV prevention drugs. Meanwhile, the Atlanta Journal-Constitution reports how reinstated CDC staff were tasked with dismantling their own departments, including the Division of HIV Prevention.

  • Federal Appeals Court Rules Alligator Alcatraz May Stay Open

    The ruling came Thursday, halting a Miami judge's ruling to break down the Everglades immigration center. Also: U.S. Rep. Yassamin Ansari (D-Ariz.) is fighting to release a woman with cancer from immigration detention; fear of deportation is putting health and hunger at risk; and more.

  • RFK Jr. Grilled Over CDC Shake-Up, Vaccine Confusion, Abortion Pill Access

    HHS Secretary Robert F. Kennedy Jr. struck a defiant tone as senators 鈥 Democrat and Republican 鈥 pressed him for answers about the direction he is taking the department. 鈥淚f we鈥檙e going to make America healthy again, we can鈥檛 allow public health to be undermined,鈥 said John Barrasso, R-Wyo. Kennedy indicated more upheaval is to come. Plus, looks at claims made during the hearing.

  • Massachusetts, New York Break With FDA On Covid Vaccine Limitations

    While Massachusetts will mandate insurance coverage for state-recommended shots, New York plans to give pharmacists the authority to offer vaccines to anyone over 3 without a prescription. Plus: Hawaii joins the West Coast Health Alliance; Georgia pumps the breaks on covid shots; and more.

  • HHS Broadens Catastrophic Coverage Eligibility On ACA Exchange

    Starting Nov. 1, Affordable Care Act participants who don't qualify for the advanced subsidies or cost-sharing reductions may apply for a hardship exemption. In other news: ACA insurers might need to revise 2026 prices; companies and their employees are looking at higher health care costs; and more.